This article is more than 5 years old. Information may no longer be current.
Cardiology Today's top articles in May
Click Here to Manage Email Alerts
Cardiology Today compiled a list of the top 5 stories posted to Healio.com/Cardiology in May.
This month, Cardiology Today readers were most interested in the effects of resveratrol in patients with diabetes, critical care for patients after procedures, a subanalysis of the FOURIER trial, data from the REVEAL-AF trial, smartwatches capable of detecting atrial fibrillation, and much more.
Resveratrol may reduce arterial stiffness in patients with diabetes
Resveratrol reversed arterial stiffness in patients with type 2 diabetes, according to an abstract presented at the American Heart Association’s Arteriosclerosis, Thrombosis and Vascular Biology/Peripheral Vascular Disease Scientific Sessions.
Cardiac critical care team leverages technology to manage patients after procedures
The cardiac critical care process can be a haphazard one, but some institutions have put together cardiac critical care teams, which bring together cardiologists, intensive care specialists and personnel from other disciplines, to manage each cardiac critical care patient comprehensively after their procedure.
FOURIER: Evolocumab reduces CV events regardless of baseline LDL, statin intensity
PHILADELPHIA — A subanalysis of the FOURIER trial presented at the National Lipid Association Scientific Sessions found that evolocumab was linked to reduction in CV events regardless of a patient’s LDL or intensity of statin therapy at baseline.
REVEAL-AF: Silent AF common in high-risk patients
CHICAGO — New data from REVEAL-AF showed that approximately 30% of patients at high risk for AF but previously undiagnosed had silent AF.
Smartwatch heart rate sensor capable of detecting AF
CHICAGO — According to a study presented at the Heart Rhythm Society Annual Scientific Sessions, the heart rate sensor of the Apple Watch can detect symptomless AF when paired with artificial intelligence.